Leerink Partners analyst Stephanie Davis maintained a Hold rating on NextGen Healthcare (NASDAQ:NXGN) Inc on Thursday, setting a price target of $22, which is approximately 0.46% above the present share price of $21.9.
Davis expects NextGen Healthcare Inc to post earnings per share (EPS) of $0.16 for the first quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Moderate Sell rating of shares in NextGen Healthcare, with an average price target of $19.33.
The analysts price targets range from a high of $21 to a low of $18.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $140 million and a net profit of $10.3 million. The company's market cap is $1.46 billion.
According to TipRanks.com, Leerink Partners analyst Stephanie Davis is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 28.3% and a 70.93% success rate.
NextGen Healthcare, Inc. engages in the development and marketing of electronic health records, practice management, revenue cycle management, and interoperability solutions. It offers the core; automation and workflow; analytics, population health, and patient engagement, interoperability; managed services; professional services; and client service and support. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.